ANI Pharmaceuticals, Inc
Insiders
Last 12 monthsSales planned on beside the trades reported on , and whether each names a .
Planned ·
$10.1M
14 notices · 128,889 sh
Oct 2025 to Oct 2026
Reported ·
$12.7M
36 sales · 0 buys
Oct 2025 to Jun 2026
The two figures cover different periods.
22 of 36 reported sales carry the 10b5-1 box.
under a no plan named▼ salesize is dollars
Form 144 notices, newest first
2026-09-15NIKHIL LALWANI, PRESIDENT & CEO$380,160
2026-09-11JEANNE THOMA, Director$71,460
2026-08-25NIKHIL LALWANI, PRESIDENT & CEO$400,518
2026-07-29STEPHEN P CAREY, SVP & CFO$499,450
2026-07-07PATRICK WALSH, Director$373,720
2026-06-08THOMAS HAUGHEY, Director$162,220
Form 4, 2026-06-10: sold 2,000 at $80.88 Form 4 ↗
2026-06-05STEPHEN P CAREY, SVP & CFO$939,470
Form 4, 2026-06-09: sold 3,312 at $80.00 Form 4 ↗
2026-05-13Walsh Patrick D, Director$795,600
2026-05-11NIKHIL LALWANI, PRESIDENT & CEO$4,266,564
Form 4, 2026-05-13: sold 55,000 at $77.57 Form 4 ↗
2026-05-11PATRICK WALSH, Director$320,820
Form 4, 2026-05-13: sold 13,973 at $80.66 Form 4 ↗
2026-03-05STEPHEN P CAREY, SVP & CFO$552,017
Form 4, 2026-03-05: sold 7,312 at $75.50 Form 4 ↗
2026-03-03PATRICK WALSH, Director$445,390
Form 4, 2026-03-03: sold 6,000 at $74.23 Form 4 ↗
2025-12-05RENATE PLAWNER TANNENBAUM 2024 RV TRUST, Director$146,070
Form 4, 2025-12-09: sold 1,800 at $81.15 Form 4 ↗